Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy
Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy
2 other identifiers
interventional
34
1 country
1
Brief Summary
The purpose of this study is to determine if giving amphetamines along with standard rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is improved, the study will also identify the areas of the brain involved with the recovery. Researchers will use motor function ratings, PET scans, functional MRI (fMRI), electroencephalographs, and transcranial magnetic stimulation (TMS) to evaluate patients. Patients participating in the study will be placed in one of two groups;
- 1.Patients receiving dextroamphetamine and routine Rehabilitation Medicine
- 2.Patients receiving a placebo "sugar pill" and routine Rehabilitation Medicine
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Apr 1998
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1998
CompletedFirst Submitted
Initial submission to the registry
November 3, 1999
CompletedFirst Posted
Study publicly available on registry
November 4, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2004
CompletedMarch 4, 2008
June 1, 2004
November 3, 1999
March 3, 2008
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Hemiparetic patients (right or left) (defined as a score of 55 or lower on Fugl-Meyer Scale) who had a single thromboembolic non-hemorrhagic infarction (documented by CT or MRI) 5 to 30 days before.
- Patients will be recruited from referrals from the community particularly from Suburban Hospital.
You may not qualify if:
- Large hemorrhagic or brain stem stroke.
- Multiple cerebral lesions with residual deficits.
- Less than 5 days after stroke or greater than 30 days after stroke.
- Age younger than 18 or older than 80 years.
- History of head injury with loss of consciousness.
- Terminal illness such as AIDS or cancer.
- Severe neurological diseases other than stroke.
- History of severe alcohol or drug abuse.
- History of psychiatric illness.
- Unstable cardiac dysrhythmia or unresponsive arterial hypertension (greater than 160/100 mmHg).
- Untreated hyperthyroidism.
- Receiving alpha-adrenergic antagonists or agonists.
- Receiving major/minor tranquilizers, clonidine, prazosin, phenytoin, GABA, benzodiazepines, scopolamine, haloperidol, other neuroleptics, barbituates.
- Degree of aphasia or cognitive deficit that makes patients unable to give informed consent.
- Pregnancy. A pregnancy test will be done on admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, 20892, United States
Related Publications (3)
Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982 Aug 27;217(4562):855-7. doi: 10.1126/science.7100929.
PMID: 7100929BACKGROUNDCrisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988 Jan;23(1):94-7. doi: 10.1002/ana.410230117.
PMID: 3345072BACKGROUNDWalker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995 Dec;26(12):2254-9. doi: 10.1161/01.str.26.12.2254.
PMID: 7491646BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 3, 1999
First Posted
November 4, 1999
Study Start
April 1, 1998
Study Completion
June 1, 2004
Last Updated
March 4, 2008
Record last verified: 2004-06